Theravance Biopharma Inc Strategic Asset Allocation Index
Theravance Biopharma Inc strategic asset allocation index. Theravance Biopharma Inc (0TB) has a Strategic Asset Allocation Index of 1.3% as of September 2025. Strategic assets (PP&E of €- plus long-term investments of €3.03 Million) total €3.03 Million, measured against net assets of €232.68 Million. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See 0TB net asset quality index to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Strategic Asset Allocation Index of Theravance Biopharma Inc (2014–2022)
Strategic asset allocation index of Theravance Biopharma Inc from 2014 to 2022. This chart shows how Theravance Biopharma Inc's Strategic Asset Allocation Index has evolved across 5 annual periods from 2014 to 2022. As of September 2025, the index stands at 1.3%, representing strategic assets of €3.03 Million against net assets of €232.68 Million EUR. Check Theravance Biopharma Inc (0TB) tangible equity ratio to evaluate the tangible quality of the company's equity base.
Theravance Biopharma Inc Strategic Asset Allocation Index by Year (2014–2022)
Theravance Biopharma Inc strategic asset allocation index by year from 2014 to 2022. The table below presents the year-by-year Strategic Asset Allocation Index for Theravance Biopharma Inc from 2014 to 2022, covering 5 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. For live market cap and overall valuation, see market cap of Theravance Biopharma Inc.
| Year | SAAI | Strategic Assets (EUR) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2022 | 11.8% | €52.00 Million | €52.00 Million | €0.00 | €441.80 Million | ▼ -33.2 pp |
| 2017 | 44.9% | €51.74 Million | €10.16 Million | €41.59 Million | €115.18 Million | ▲ +14.1 pp |
| 2016 | 30.8% | €108.03 Million | €8.46 Million | €99.56 Million | €350.23 Million | ▲ +5.9 pp |
| 2015 | 25.0% | €60.73 Million | €9.87 Million | €50.86 Million | €243.06 Million | ▲ +3.9 pp |
| 2014 | 21.1% | €61.06 Million | €9.66 Million | €51.40 Million | €289.79 Million | — |